Fined 900000 yuan, Shanghai Pharmaceutical Company gave doctors 24000 yuan in "labor fees" and "lecture fees" in the market | drugs | lecture fees
According to the administrative penalty information publicly released by the Shanghai Municipal Administration for Market Regulation, the Shanghai branch of Weicai Pharmaceutical Co., Ltd. paid physicians property in violation of relevant provisions of the Drug Administration Law, and was fined 900000 yuan by the Shanghai Municipal Administration for Market Regulation on May 9 this year.
The Shanghai Municipal Administration for Market Regulation filed an investigation into the parties involved on September 21, 2022 in accordance with the law.
After investigation, from November 2019 to October 2022, the parties involved paid 14 fees, totaling 24000 yuan, to the attending physician of an intervention department at Zhengzhou University First Affiliated Hospital, who used rabeprazole sodium enteric coated tablets, cilantro tartrate tablets, and teprenone capsules registered with Weicai Pharmaceutical Co., Ltd. under the names of "labor fees" and "lecture fees".
These 14 fees range from 1000 to 2000 yuan per transaction, and the parties involved will use the name of the attending physician of a certain interventional department at the First Affiliated Hospital of Zhengzhou University to hold a work meeting in the hospital's internal premises during working hours for 14 times. The funds will be paid to them through bank account transfers.
![Fined 900000 yuan, Shanghai Pharmaceutical Company gave doctors 24000 yuan in "labor fees" and "lecture fees" in the market | drugs | lecture fees](https://a5qu.com/upload/images/9b6e5c9f3227e07cbc639b3b94501340.png)
Related content of administrative penalty decision
According to the Drug Administration Law, holders of drug marketing licenses, drug production enterprises, drug trading enterprises, or agents are prohibited from giving any property or other improper benefits to the responsible persons, drug procurement personnel, physicians, pharmacists, and other relevant personnel of medical institutions using their drugs in any name.
Violators shall have their illegal gains confiscated by the market supervision department and be fined between 300000 yuan and 3 million yuan; If the circumstances are serious, the holder of the drug marketing license, the business license of the drug production enterprise, or the drug trading enterprise shall be revoked, and the drug regulatory department shall revoke the drug approval certificate, drug production license, and drug business license.
The public administrative penalty decision shows that the parties involved have a clear understanding of their mistake after the incident, actively cooperate with the investigation, provide authentic and effective evidence materials, and truthfully explain the truth of the case; Actively implement rectification, stop paying fees to relevant doctors, and modify and improve the company's compliance system and approval process. Considering the above factors and confirming that the party involved has committed the crime for the first time, the regulatory authorities have decided to impose a lighter punishment on the party in accordance with the law and regulations.
![Fined 900000 yuan, Shanghai Pharmaceutical Company gave doctors 24000 yuan in "labor fees" and "lecture fees" in the market | drugs | lecture fees](https://a5qu.com/upload/images/fe0fac7d0933923ba713b6a675274853.png)
According to the National Enterprise Credit Information Publicity System, Weicai Pharmaceutical Co., Ltd. Shanghai Branch was established on July 6, 2006 and registered in Jing'an District, Shanghai. Its business scope includes providing management consulting services, medical technology consulting services, etc.